Page 2 - இந்தியா ப்ரொஃபெஶநல் காங்கிரஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Apr 09, 2021, 15:39 IST By M Somasekhar When Hyderabad-based Pharma major, Dr Reddy’s announced that it was partnering the RIDF, Moscow to undertake clinical trials and distribute the Sputnik V vaccine in India in the September 2020, as the global pandemic was spreading fast, it raised both public and market interest.  In March 2021, Dr Reddy’s says, its just weeks before the Vaccine could get clearance from Indian regulators for use. In the meantime, atleast half a dozen Indian drug majors have entered into tie-ups with the RIDF, the Russian Sovereign Fund for production.  Interestingly, with four of these drug companies located in Hyderabad, the city is fast turning out to be the biggest Hub for the Russian Vaccine. Dr Reddy’s with its bold step is leading the pack with the others being Hetero Biopharma, Gland Pharma and Virchow Biotech. Each of these three companies will produce the vaccine. It may be noted that the representatives of the RIDF had met several co

Andhra pradeshZydus cadilaNarendra modiAurobindo pharmaAdar poonawalaDeepak sapraStelis biopharmaOxford astrazenecaServices of dr reddyUnion healthIndia professional congressRussian sovereign fundIndian immunological ltdGemaleya national research institute of epidemiologySerum institute of indiaHyderabad based pharma